Clinical Trial Update: DyeVert™ Plus Contrast Reduction System Multicenter Observational Study

View source ↗

Summary

Multicenter observational study on the DyeVert Plus Contrast Reduction System completed; results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• DyeVert Plus Contrast Reduction System

Snippet

Sponsor: Osprey Medical, Inc | Conditions: Chronic Kidney Disease | Status: COMPLETED | Results posted: 2020-10-19